A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
The Daily Galaxy on MSN
From Frankenstein to Reality: Five Experiments Where Science Crossed the Line Into Fiction
When Mary Shelley publishedFrankenstein; or, The Modern Prometheus in 1818, she wasn’t just writing a gothic horror novel—she ...
Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
A leading bioethicist at Hiroshima University is calling for an anticipatory, rather than reactive, approach to ethics after ...
Silicon Valley billionaires love to chase extreme health tech. Their next obsession, after dabbling in tech to reverse aging, ...
Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...
The “plausible mechanism pathway” will allow personalised drugs to reach the market sooner for patients with genetic diseases ...
A clandestine startup privately funded by tech billionaires is looking into germline gene editing a human embryo.
The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell therapies, and precision medicine driving innovation. Increased awareness and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback